Systemic and pulmonary hemodynamics in patients with non-cirrhotic portal fibrosis (NCPF) is similar to compensated cirrhosis
- PMID: 19669349
- PMCID: PMC2720720
- DOI: 10.1007/s12072-007-5006-8
Systemic and pulmonary hemodynamics in patients with non-cirrhotic portal fibrosis (NCPF) is similar to compensated cirrhosis
Abstract
Background: Non-cirrhotic portal fibrosis (NCPF) is an important cause of portal hypertension (PHT) and variceal bleeding, especially in the developing countries. While the hepatic parenchyma and liver functions are normal, the patho-anatomic defect in these patients is pre- and peri-sinusoidal in nature.
Aim: To study the systemic and pulmonary hemodynamic alterations in patients with NCPF and compare them with compensated cirrhotic patients.
Patients and methods: Patients with NCPF (n = 20, mean age 29.3 +/- 9.8 year) and matched Child's A cirrhotic patients (n = 17, age 34.1 +/- 9.8 year) who had bled in the past, underwent hemodynamic measurements using a balloon tipped catheter.
Results: In NCPF patients, the hepatic venous pressure gradient (HVPG) was significantly lower than in the cirrhotic patients (4.9 +/- 1.5 mmHg vs. 15.7 +/- 4.5 mmHg; P < 0.01). NCPF patients had hyperdynamic circulation and peripheral vasodilatation comparable to cirrhotic patients; cardiac output (8.0 +/- 1.2 l/min vs. 8.4 +/- 1.9 l/min; P = 0.4), cardiac index (5.4 +/- 0.8 l/min/m(2) vs. 5.5 +/- 1.9 l/min/m(2); P = 0.86), mean arterial pressure (88.2 +/- 14.1 mmHg vs. 89.9 +/- 17.3 mmHg; P = 0.73), systemic vascular resistance (852.8 +/- 204.3 dynes . s/cm(5) vs. 854.1 +/- 189.9 dynes . s/cm(5); P = 0.98) and pulmonary vascular resistance (41.6 +/- 18.1 dynes . s/cm(5) vs. 41.3 +/- 17.9 dynes . s/cm(5); P = 0.95) were comparable in the two groups.
Conclusions: NCPF associated portal hypertension leads to a hyperdynamic state with high cardiac index and low systemic and pulmonary vascular resistance comparable to compensated cirrhosis. These novel observations suggest a primary role of portal hypertension in the development of hyperdynamic state.
References
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PMC', 'value': 'PMC1378468', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC1378468/'}, {'type': 'PubMed', 'value': '2651229', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/2651229/'}]}
- Sarin SK. Non-cirrhotic portal fibrosis. Gut 1989; 5:336–51 - PMC - PubMed
-
- None
- Imai F, Kuga K, Komaba M, et al. Interim report on IPH survey. In: Futagawa S (ed) 1992 Report of the research committee on aberrant portal hemodynamics. Tokyo: Ministry of Health and Welfare; 1993. p. 107–10
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/0002-9343(71)90234-8', 'is_inner': False, 'url': 'https://doi.org/10.1016/0002-9343(71)90234-8'}, {'type': 'PubMed', 'value': '5315322', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/5315322/'}]}
- Sama SK, Bhargawa S, Gopi Nath N, et al. Non-cirrhotic portal fibrosis. Am J Med 1971; 51:160–9 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1046/j.1440-1746.2002.02660.x', 'is_inner': False, 'url': 'https://doi.org/10.1046/j.1440-1746.2002.02660.x'}, {'type': 'PubMed', 'value': '11895548', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11895548/'}]}
- Okuda K. Non-cirrhotic portal hypertension: why is it so common in India. J Gastroenterol Hepatol 2002; 17:1–5 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '3544224', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/3544224/'}]}
- Bosch J, Mastai R, Kravetz D, et al. Hemodynamic evaluation of the patient with portal hypertension. Semin Liver Dis 1986; 6:309–17 - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous